Skip to main content
Erschienen in: Diabetology International 2/2017

04.11.2016 | Original Article

Reliability and validity of revised and short form versions of diabetes diet-related quality of life scale

verfasst von: Eiko Sato, Ryota Ochiai, Taiga Shibayama, Masakazu Nishigaki, Yoshiki Abe, Tasuku Sawa, Yoshimi Suzukamo, Keiko Kazuma

Erschienen in: Diabetology International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To develop both a revised version of the Diabetes Diet-Related Quality of Life (DDRQOL-R) scale that can be applied to patients with nephropathy and a short form of the DDRQOL-R.

Method

A total of 184 outpatients with type 2 diabetes were asked to complete the self-administered DDRQOL-R scale to confirm its psychometric properties. A short-form version was developed, based on two methods: the result of the developed DDRQOL-R scale and consensus using the Delphi method among medical experts.

Results

Correlations were generally strong between the DDRQOL-R factors extracted by factor analysis and each SF-36 subscale. Cronbach’s α coefficients were at least 0.7, and intraclass correlation coefficients were between 0.59 and 0.78. The nine items that showed high factor loadings were also assessed as important by the medical experts and were selected for the short form of the scale. The reliability and validity of the short form were found to be similar to those of the DDRQOL-R scale.

Discussion

Our findings indicate that the DDRQOL-R scale and its short form have acceptable reliability and validity. The revised version is highly versatile, and the short form can be conveniently administered.
Literatur
3.
Zurück zum Zitat American Diabetes Association. Foundations of care and comprehensive medical evaluation. Diabetes Care. 2016;39(Suppl 1):S23–35. American Diabetes Association. Foundations of care and comprehensive medical evaluation. Diabetes Care. 2016;39(Suppl 1):S23–35.
4.
Zurück zum Zitat Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med. 2005;22(10):1379–85.CrossRefPubMed Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med. 2005;22(10):1379–85.CrossRefPubMed
5.
Zurück zum Zitat Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31.CrossRefPubMed Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31.CrossRefPubMed
6.
Zurück zum Zitat Wardian J, Sun F. Factors associated with diabetes-related distress: implications for diabetes self-management. Soc Work Health Care. 2014;53(4):364–81.CrossRefPubMedPubMedCentral Wardian J, Sun F. Factors associated with diabetes-related distress: implications for diabetes self-management. Soc Work Health Care. 2014;53(4):364–81.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Chew BH, Mohd-Sidik S, Shariff-Ghazali S. Negative effects of diabetes-related distress on health-related quality of life: an evaluation among the adult patients with type 2 diabetes mellitus in three primary healthcare clinics in Malaysia. Health Qual Life Outcomes. 2015;13:187.CrossRefPubMedPubMedCentral Chew BH, Mohd-Sidik S, Shariff-Ghazali S. Negative effects of diabetes-related distress on health-related quality of life: an evaluation among the adult patients with type 2 diabetes mellitus in three primary healthcare clinics in Malaysia. Health Qual Life Outcomes. 2015;13:187.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Pintaudi B, Lucisano G, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, Rossi MC, Nicolucci A, BENCH-D Study Group. Correlates of diabetes-related distress in type 2 diabetes: Findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study. J Psychosom Res. 2015;79(5):348–54.CrossRefPubMed Pintaudi B, Lucisano G, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, Rossi MC, Nicolucci A, BENCH-D Study Group. Correlates of diabetes-related distress in type 2 diabetes: Findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study. J Psychosom Res. 2015;79(5):348–54.CrossRefPubMed
9.
Zurück zum Zitat Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15(3):205–18.CrossRefPubMed Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15(3):205–18.CrossRefPubMed
11.
Zurück zum Zitat The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef
12.
Zurück zum Zitat The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care. 1988;11(9):725–32.CrossRef The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care. 1988;11(9):725–32.CrossRef
13.
Zurück zum Zitat Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(5):754–60.CrossRefPubMed Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(5):754–60.CrossRefPubMed
14.
Zurück zum Zitat Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996;19(2):208–30.CrossRefPubMed Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996;19(2):208–30.CrossRefPubMed
15.
Zurück zum Zitat Meadows K, Steen N, McColl E, Eccles M, Shiels C, Hewison J, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients–development and psychometric evaluation. Qual Life Res. 1996;5(2):242–54.CrossRefPubMed Meadows K, Steen N, McColl E, Eccles M, Shiels C, Hewison J, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients–development and psychometric evaluation. Qual Life Res. 1996;5(2):242–54.CrossRefPubMed
16.
Zurück zum Zitat Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care. 1998;21(5):757–69.CrossRefPubMed Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care. 1998;21(5):757–69.CrossRefPubMed
17.
Zurück zum Zitat Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care. 1997;35(5):440–53.CrossRefPubMed Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care. 1997;35(5):440–53.CrossRefPubMed
18.
Zurück zum Zitat Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8(1–2):79–91.CrossRefPubMed Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8(1–2):79–91.CrossRefPubMed
19.
Zurück zum Zitat Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–52.CrossRefPubMedPubMedCentral Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–52.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ishii H, Yamamoto T, Ohashi Y. Development of insulin therapy related quality of life measure (ITR-QOL). J Jpn Diabetes Soc. 2001;44(1):9–15. Ishii H, Yamamoto T, Ohashi Y. Development of insulin therapy related quality of life measure (ITR-QOL). J Jpn Diabetes Soc. 2001;44(1):9–15.
22.
Zurück zum Zitat Sato E, Suzukamo Y, Miyashita M, Kazuma K. Development of a diabetes diet-related quality-of-life scale. Diabetes Care. 2004;27(6):1271–5.CrossRefPubMed Sato E, Suzukamo Y, Miyashita M, Kazuma K. Development of a diabetes diet-related quality-of-life scale. Diabetes Care. 2004;27(6):1271–5.CrossRefPubMed
23.
Zurück zum Zitat Ahlgren SS, Shultz JA, Massey LK, Hicks BC, Wysham C. Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Qual Life Res. 2004;13(4):819–32.CrossRefPubMed Ahlgren SS, Shultz JA, Massey LK, Hicks BC, Wysham C. Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Qual Life Res. 2004;13(4):819–32.CrossRefPubMed
24.
Zurück zum Zitat Ishii H, Furuya M, Iburi T, Yamagami K, Ishibashi R, Tsujii S. Insulin therapy related QOL at night (ITR-QOLN). J Jpn Diabetes Soc. 2008;51(7):593–600. Ishii H, Furuya M, Iburi T, Yamagami K, Ishibashi R, Tsujii S. Insulin therapy related QOL at night (ITR-QOLN). J Jpn Diabetes Soc. 2008;51(7):593–600.
25.
Zurück zum Zitat Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–44.CrossRefPubMed Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–44.CrossRefPubMed
26.
Zurück zum Zitat Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol. 1998;51(11):1045–53.CrossRefPubMed Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol. 1998;51(11):1045–53.CrossRefPubMed
27.
Zurück zum Zitat Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese version. Kyoto: Institute for Health Outcomes and Process Evaluation Research; 2004. Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese version. Kyoto: Institute for Health Outcomes and Process Evaluation Research; 2004.
28.
Zurück zum Zitat Pope C, Mays N, editors. Qualitative research in health care. 3rd ed. London: BMJ Books; 2006. Pope C, Mays N, editors. Qualitative research in health care. 3rd ed. London: BMJ Books; 2006.
29.
Zurück zum Zitat Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. Clin Exp Nephrol. 2015;19(1):1–5.CrossRefPubMed Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. Clin Exp Nephrol. 2015;19(1):1–5.CrossRefPubMed
30.
Zurück zum Zitat Ikegami N, Shimotuma K, Fukuhara S. Quality of life evaluation handbook for clinicians. Tokyo: Igakushoin; 2001. Ikegami N, Shimotuma K, Fukuhara S. Quality of life evaluation handbook for clinicians. Tokyo: Igakushoin; 2001.
31.
Zurück zum Zitat Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20(4):562–7.CrossRefPubMed Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20(4):562–7.CrossRefPubMed
32.
Zurück zum Zitat Landis J, Koch G. The measurement of observer agrement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed Landis J, Koch G. The measurement of observer agrement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed
33.
Zurück zum Zitat Fayers P, Machin D, editors. Quality of life: assessment, analysis and interpretation. Chichester: Wiley; 2000. Fayers P, Machin D, editors. Quality of life: assessment, analysis and interpretation. Chichester: Wiley; 2000.
34.
Zurück zum Zitat Yokoyama H, Kawai K, Kobayashi M, Japan Diabetes Clinical Data Management Study Group. Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10). Diabetes Care. 2007;30(4):989–92.CrossRefPubMed Yokoyama H, Kawai K, Kobayashi M, Japan Diabetes Clinical Data Management Study Group. Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10). Diabetes Care. 2007;30(4):989–92.CrossRefPubMed
35.
Zurück zum Zitat Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–34.CrossRefPubMed Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–34.CrossRefPubMed
Metadaten
Titel
Reliability and validity of revised and short form versions of diabetes diet-related quality of life scale
verfasst von
Eiko Sato
Ryota Ochiai
Taiga Shibayama
Masakazu Nishigaki
Yoshiki Abe
Tasuku Sawa
Yoshimi Suzukamo
Keiko Kazuma
Publikationsdatum
04.11.2016
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 2/2017
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-016-0291-x

Weitere Artikel der Ausgabe 2/2017

Diabetology International 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.